Prescription Drug Board’s Payment Caps Expanded in Maryland

Maryland’s prescription drug affordability board would have authority to limit what commercial health plans pay for certain drugs in the state under a bill passed by the legislature Monday.

The bill (HB 424) builds on the 2019 law setting up the Maryland Prescription Drug Affordability Board by expanding the caps for state-run health plans to also apply to any health payer in the state. The legislation, if signed by Gov. Wes Moore (D), will take effect Oct. 1, 2025, and would have Maryland join Colorado, Minnesota, and Washington with the ability to control what any health plan pays ...